Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate PledOx for prevention of chronic chemotherapy induced peripheral
neuropathy induced by oxaliplatin in patients with Stage III or high-risk Stage II colorectal
cancer (CRC).